Table 1 Demographic and clinical baseline characteristics of diabetic subjects
Demographic and clinical baseline characteristics of diabetic subjects | |||||
|---|---|---|---|---|---|
No retinopathy group | Minimal NPDR group | Severe NPDR group | PDR group | P value | |
Subjects | 10 Subjects | 10 Subjects | 12 Subjects | 19 Subjects | |
(Eyes) | (10 eyes) | (10 eyes) | (12 eyes) | (19 eyes) | |
Age | 0.92 | ||||
Mean | 55.5 | 56.6 | 53 | 50 | |
(SD) | (8.9) | (9.5) | (9.0) | (12.5) | |
(Range) | (43–65) | (37–65) | (41 – 65) | (26–65) | |
Female | 60% | 50% | 42% | 58% | 0.21 |
Type II Diabetes | 70% | 80% | 83% | 73% | 0.70 |
Duration of DM in months: Mean | 118 | 148 | 128 | 211 | <0.05 |
(SD) | (65) | (74) | (93) | (124) | |
(Range) | (24–144) | (37–240) | (12–300) | (2–456) | |
Hypertension | 50% | 70% | 67% | 48% | 0.74 |
High Cholesterol | 40% | 70% | 34% | 57% | 0.16 |
Associated microvascular complications | 0.44 | ||||
NONE | 80% | 70% | 59% | 63% | |
IHD, CVA, TIA | 10% | 20% | 0% | 5% | |
Neuropathy, Foot Ulcer | 10% | 10% | 25% | 10% | |
Nephropathy | 0% | 0% | 17% | 21% | |
Smoking | 20% | 30% | 17% | 21% | 0.8 |